Calcineurin Inhibitors and Uric Acid Control in Solid Organ Transplantation: A Systematic Review
Medical Sciences · 10.04.2026 · 14 (2) · 191
DOI: 10.3390/medsci14020191 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medical Sciences, online erschienen am 10.04.2026. Verfasst von Francesca K Martino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Dialysis and Transplantation Unit, Department of Medicine (DIMED), University of Padova, 35128 Padua, Italy. Hauptthemen laut MEDLINE: Calcineurin Inhibitors, Uric Acid, Organ Transplantation, Hyperuricemia. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Asymptomatic hyperuricemia has been associated with increased cardiovascular risk; it is related to factors such as diet, genetic predisposition, and drug-related side effects. Impairment of uric acid control has been associated with the calcineurin inhibitors cyclosporin and tacrolimus, although available studies did not reach the same conclusions. Their widespread use in solid organ transplantation potentially exposes this population to higher cardiovascular risk. This systematic review aimed to assess their role in hyperuricemia risk compared with other immunosuppressive treatments and to clarify potential differences between cyclosporin and tacrolimus.
Methods
The search was conducted in MEDLINE and Embase, limited to adult subjects, using the following terms: ((cyclosporin) OR (cyclosporine) OR (tacrolimus) OR (calcineurin inhibitor)) AND ((uric acid) OR (urate) OR (hyperuricemia)) AND ((transplant) OR (transplantation)). We assessed the quality of the studies according to the Critical Appraisal Skills Programme checklist.
Results
After screening 639 manuscripts, we selected 36 studies that were relevant to our focus: 28 evaluated kidney transplant patients, while only eight focused on other solid organ transplants. Specifically, 20 studies compared calcineurin inhibitors with other immunosuppressants, while 15 assessed the impact of cyclosporin versus tacrolimus, and one study contributed to both scenarios. The prevalence of hyperuricemia ranged from 30 to 80% among patients receiving calcineurin inhibitors, with a slightly higher prevalence with cyclosporin than with tacrolimus (51–61% vs. 36–42%, respectively). The overall quality of the included studies was generally rated as low to moderate, with only ten studies focusing on uric acid control.
Conclusions
Given the heterogeneity and overall quality of the available studies, no definitive conclusions can be drawn. In particular, the comparative effect of cyclosporin and tacrolimus remains uncertain because of conflicting findings across studies. Although calcineurin inhibitors may adversely affect uric acid control in transplant recipients, this association may be influenced by several confounding factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nephrology, Dialysis and Transplantation Unit, Department of Medicine (DIMED), University of Padova, 35128 Padua, Italy.
ORCID-Profile: Francesca K Martino, Leda Cattarin, Federico Nalesso
Zitieren
APA
Martino, F. K., Bogo, M., Brunetta, L., Fioretti, F., Cattarin, L., Stefanelli, L. F., & Nalesso, F. (2026). Calcineurin Inhibitors and Uric Acid Control in Solid Organ Transplantation: A Systematic Review. Medical Sciences, 14(2), 191. https://doi.org/10.3390/medsci14020191
Vancouver
Martino FK, Bogo M, Brunetta L, Fioretti F, Cattarin L, Stefanelli LF, et al. Calcineurin Inhibitors and Uric Acid Control in Solid Organ Transplantation: A Systematic Review. Medical Sciences. 2026;14(2):191. doi:10.3390/medsci14020191
BibTeX
@article{Martino2026,
author = {Martino, Francesca K and Bogo, Marco and Brunetta, Ludovica and Fioretti, Francesca and Cattarin, Leda and Stefanelli, Lucia F and Nalesso, Federico},
title = {Calcineurin Inhibitors and Uric Acid Control in Solid Organ Transplantation: A Systematic Review},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {191},
doi = {10.3390/medsci14020191}
}
EUVIMED